Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
Public ClinicalTrials.gov record NCT05322941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group, Phase 2b Study in Treatment-seeking Patients With Cannabis Use Disorder to Assess the Efficacy, Safety, and Tolerability of AEF0117 in Reducing Cannabis Use
Study identification
- NCT ID
- NCT05322941
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aelis Farma
- Industry
- Enrollment
- 333 participants
Conditions and interventions
Conditions
Interventions
- AEF0117 Drug
- Placebo oral capsule Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2022
- Primary completion
- Apr 10, 2024
- Completion
- Jul 21, 2024
- Last update posted
- Jul 29, 2024
2022 – 2024
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedar clinical research | Phoenix | Arizona | 85021 | — |
| CenExel CNR | Garden Grove | California | 82845 | — |
| UCLA Department of Psychiatry and Biobehavioral Sciences | Los Angeles | California | 90095 | — |
| Yale Stress Center - Addiction Program | New Haven | Connecticut | 06520 | — |
| Segal Trial | Lauderhill | Florida | 33319 | — |
| Behavioral Clinical Research | Miami Lakes | Florida | 33016 | — |
| The Substance Treatment and Research Service (S.T.A.R.S.) of Columbia University/NYSPI. | New York | New York | 10032 | — |
| CODA, Inc Research Department | Portland | Oregon | 97214 | — |
| Addiction Sciences Division Department of Psychiatry and Behavioral Sciences Medical University of South Carolina | Charleston | South Carolina | 29425-8640 | — |
| Department of Psychiatry and Behavioral Sciences at UT Health San Antonio. | San Antonio | Texas | 78218 | — |
| Cedar Clinical Research | Draper | Utah | 84020 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05322941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2024 · Synced May 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05322941 live on ClinicalTrials.gov.